The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFiltronic Regulatory News (FTC)

Share Price Information for Filtronic (FTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 47.00
Bid: 46.00
Ask: 48.00
Change: -0.50 (-1.05%)
Spread: 2.00 (4.348%)
Open: 48.00
High: 49.00
Low: 46.50
Prev. Close: 47.50
FTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update & Notice of Final Results

23 Jun 2023 07:00

RNS Number : 6512D
Filtronic PLC
23 June 2023
 

 

23 June 2023

Filtronic plc

("Filtronic")

 

YEAR END TRADING UPDATE, CONTRACT WINS AND NOTICE OF RESULTS

 

Trading Momentum Maintained, Supply Chain Constraints Easing and Strategic Market Growth

 

Filtronic plc (AIM: FTC), the designer and manufacturer of products for the aerospace, defence, telecoms infrastructure and critical communications markets, is pleased to provide the following trading update for the financial year ended 31 May 2023 ("FY2023").

 

Revenue and adjusted EBITDA have been delivered in line with market expectations with positive news that the supply chain issues eased in the final quarter of the financial year. Our opportunity pipeline continues to build, and we are delighted to have won two new contracts post period end, each valued at £0.5m.

 

Financial highlights

 

Trading in H2 of the financial year was in line with market expectations for both revenue and adjusted EBITDA. Therefore, subject to audit, the Board expects to report FY2023 revenue of approximately £16.3m (FY2022: £17.1m) and adjusted EBITDA of approximately £1.3m (FY2022: £2.7m). Cash at bank on 31 May 2023 was £2.6m (30 November 2022: £3.0m). Net cash (net of all lease obligations except right of use property leases) at 31 May 2023 was £1.9m (30 November 2022: £2.4m).

 

Operational highlights

 

The FY2023 full year results are a testament to the ability of the business to operate with agility and speed during uncertain times. Having experienced component shortages in the year, which constrained revenue generation, we were able to execute a quick ramp of production once supply was restored whilst continuing to scale the business to respond to the opportunities that are emerging for mmWave RF technology.

 

Of our four core markets, it is the low earth orbit ("LEO") space opportunity that has exceeded our expectations in terms of both the size of the opportunity and the speed of deployment. We are engaged with the leading players in this segment, where there is increasing demand for high bandwidth and high frequency backhaul communications between the satellite and the ground station. We secured our first production order for E-band ground station solid state power amplifiers from a market leader during the second half of the year and have exceeded expectations in terms of both delivery and technical performance. Our RF technology is a potential key enabler in this sector, and we are committed to building the organisation necessary to execute our technology roadmap and continue to engage with the major industry players and relevant government agencies.

 

Demand for telecommunication infrastructure products increased steadily throughout the year with the opening of the newly licenced Indian market offsetting the abrupt closure of the Russian 5G rollout last year. Our inability to execute orderbook due to component shortages did not diminish the need for innovative new products in the telecommunications market and we announced our new Morpheus X2, Hades X2 and Hercules X2 products within the year, securing advanced production orders for delivery in FY2024 on all three platforms. We continue to look for opportunities adjacent to the primary telecoms infrastructure market and were delighted to receive two new contract wins for products going into private telecommunications networks this month. The contracts valued at £0.5m each are for delivery in 2024 and are the result of many years of collaborative design effort with our customers.

 

The conflict in Ukraine and increased geopolitical tensions increased the focus on the aerospace and defence market during the trading period and we have continued to make good progress, securing follow-on orders for development programme wins registered in the prior year. Increased business development and marketing activities are also starting to yield positive results with several development contract wins from influential players in the electronic warfare (EW) market. This development roadmap is supported by an opportunity pipeline that continues to build in terms of both quality and value based on the need for a UK sovereign defence supply chain.

 

Results for the financial year ended 31 May 2023 will be announced on 1 August 2023.

 

Richard Gibbs, Chief Executive Officer, said:

"Throughout the year our primary markets have remained robust, and we enter the new financial year with a strong order book, a significant number of promising development programmes and opportunity pipeline that has doubled during the course of the last year. Notwithstanding the disruptions caused by shortages of electronic components, we believe that we are continuing to make the right investments in the business to capitalise on the exciting near-term opportunities in our core markets. We have been encouraged by the closing of two new telecoms infrastructure contracts early in our new trading year and will look to build further momentum as the year progresses".

 

 

Enquiries:

Filtronic plc

Tel. 01740 618800 or investor.relations@filtronic.com

Richard Gibbs (Chief Executive Officer)

 

Michael Tyerman (Chief Financial Officer)

 

 

finnCap Limited

Tel. 020 7220 0500

Jonny Franklin-Adams/George Dollemore (Corporate Finance)

Alice Lane / Sunila de Silva (ECM)

 

 

Walbrook PR Limited

Tel. 020 7933 8780 or filtronic@walbrookpr.com

Paul Vann

Mob. 07768 807 631

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSESFMEEDSEEM
Date   Source Headline
24th Apr 20247:00 amRNSTrading Update
24th Apr 20247:00 amRNSStrategic Agreement with SpaceX
9th Apr 20242:30 pmRNSHolding(s) in Company
2nd Apr 20247:00 amRNSDirectorate Change
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
12th Mar 20241:37 pmRNSExercise of Options and Total Voting Rights
13th Feb 20247:00 amRNSHolding(s) in Company
8th Feb 20245:47 pmRNSExercise of Options, Director Dealing and TVR
8th Feb 20248:19 amRNSHolding(s) in Company
6th Feb 20247:00 amRNSInterim Results
6th Feb 20247:00 amRNSNew £7.8m Contract Award
16th Jan 20244:28 pmRNSHolding(s) in Company
15th Jan 20247:00 amRNSContract win with QinetiQ for Defence Radar
20th Dec 20237:00 amRNSNew £4.8 million Contract Award
19th Dec 20237:00 amRNSNew £4.5 million Contract Award
1st Dec 20234:39 pmRNSGrant of Options
23rd Nov 20237:00 amRNSPresentations at Mello Investor Conference
26th Oct 20232:25 pmRNSResult of AGM
26th Oct 20237:00 amRNSAGM Trading Update & Notice of Results
6th Oct 202310:58 amRNSHolding(s) in Company
6th Oct 20237:00 amRNSDirector Dealing
21st Sep 20237:00 amRNSNew £3.4m LEO Space Market contract award
20th Sep 20237:00 amRNSNotice of AGM & Posting of Annual Report
19th Sep 20237:00 amRNSChange of Auditor
18th Sep 20237:00 amRNSGrant Funding Project Win
1st Aug 20237:00 amRNSFinal Results
21st Jul 20237:00 amRNSNew £3.2m Contract Award by European Space Agency
4th Jul 20231:11 pmRNSHolding(s) in Company
23rd Jun 20237:00 amRNSTrading Update & Notice of Final Results
23rd May 20237:00 amRNSHolding(s) in Company
22nd May 20233:05 pmRNSHolding(s) in Company
20th Apr 20237:00 amRNSNew 5G Contract Award
6th Apr 202310:25 amRNSHolding(s) in Company
3rd Apr 20237:00 amRNSNew Contract Award
7th Mar 20234:45 pmRNSHolding(s) in Company
8th Feb 202310:08 amRNSDirector/PDMR Dealing
7th Feb 20233:46 pmRNSDirector/PDMR Dealing
7th Feb 20237:00 amRNSInterim Results
31st Jan 20237:00 amRNSNew Contract Award and Trading Update
13th Jan 202311:00 amRNSHolding(s) in Company
9th Dec 20224:40 pmRNSSecond Price Monitoring Extn
9th Dec 20224:35 pmRNSPrice Monitoring Extension
11th Nov 202211:33 amRNSExercise of Options and Issue of Equity
27th Oct 202211:44 amRNSResult of AGM
27th Oct 20227:00 amRNSAGM Statement & Notice of Interim Results
24th Oct 202211:05 amRNSHolding(s) in Company
28th Sep 20222:06 pmRNSSecond Price Monitoring Extn
28th Sep 20222:01 pmRNSPrice Monitoring Extension
28th Sep 202211:06 amRNSSecond Price Monitoring Extn
28th Sep 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.